These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39054282)

  • 1. Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of
    Wichmann CW; Morgan KA; Cao Z; Osellame LD; Guo N; Gan H; Reilly E; Burvenich IJG; O'Keefe GJ; Donnelly PS; Scott AM
    J Nucl Med; 2024 Sep; 65(9):1456-1462. PubMed ID: 39054282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of CD46 targeted alpha theranostics in prostate cancer using
    Bobba KN; Bidkar AP; Wadhwa A; Meher N; Drona S; Sorlin AM; Bidlingmaier S; Zhang L; Wilson DM; Chan E; Greenland NY; Aggarwal R; VanBrocklin HF; He J; Chou J; Seo Y; Liu B; Flavell RR
    Theranostics; 2024; 14(4):1344-1360. PubMed ID: 38389832
    [No Abstract]   [Full Text] [Related]  

  • 3. Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR.
    Panousis C; Rayzman VM; Johns TG; Renner C; Liu Z; Cartwright G; Lee FT; Wang D; Gan H; Cao D; Kypridis A; Smyth FE; Brechbiel MW; Burgess AW; Old LJ; Scott AM
    Br J Cancer; 2005 Mar; 92(6):1069-77. PubMed ID: 15770208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient 1-step radiolabeling of monoclonal antibodies to high specific activity with 225Ac for α-particle radioimmunotherapy of cancer.
    Maguire WF; McDevitt MR; Smith-Jones PM; Scheinberg DA
    J Nucl Med; 2014 Sep; 55(9):1492-8. PubMed ID: 24982438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha radioimmunotherapy using
    Cheal SM; McDevitt MR; Santich BH; Patel M; Yang G; Fung EK; Veach DR; Bell M; Ahad A; Vargas DB; Punzalan B; Pillarsetty NVK; Xu H; Guo HF; Monette S; Michel AO; Piersigilli A; Scheinberg DA; Ouerfelli O; Cheung NV; Larson SM
    Theranostics; 2020; 10(25):11359-11375. PubMed ID: 33052220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-PET quantitation of de2-7 epidermal growth factor receptor expression in glioma using 124I-IMP-R4-labeled antibody ch806.
    Lee FT; O'Keefe GJ; Gan HK; Mountain AJ; Jones GR; Saunder TH; Sagona J; Rigopoulos A; Smyth FE; Johns TG; Govindan SV; Goldenberg DM; Old LJ; Scott AM
    J Nucl Med; 2010 Jun; 51(6):967-72. PubMed ID: 20484439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-Tyrosine Confers Residualizing Properties to a d-Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies.
    Lee FT; Burvenich IJ; Guo N; Kocovski P; Tochon-Danguy H; Ackermann U; O'Keefe GJ; Gong S; Rigopoulos A; Liu Z; Gan HK; Scott AM
    Mol Imaging; 2016; 15():. PubMed ID: 27457521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of
    Bobba KN; Bidkar AP; Meher N; Fong C; Wadhwa A; Dhrona S; Sorlin A; Bidlingmaier S; Shuere B; He J; Wilson DM; Liu B; Seo Y; VanBrocklin HF; Flavell RR
    J Nucl Med; 2023 Jul; 64(7):1076-1082. PubMed ID: 37201957
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of an Anti-HER2 Nanobody Labeled with
    Pruszynski M; D'Huyvetter M; Bruchertseifer F; Morgenstern A; Lahoutte T
    Mol Pharm; 2018 Apr; 15(4):1457-1466. PubMed ID: 29502411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer.
    Rodak M; Dekempeneer Y; Wojewódzka M; Caveliers V; Covens P; Miller BW; Sevenois MB; Bruchertseifer F; Morgenstern A; Lahoutte T; D'Huyvetter M; Pruszyński M
    Mol Cancer Ther; 2022 Dec; 21(12):1835-1845. PubMed ID: 36129807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer.
    Manning HC; Merchant NB; Foutch AC; Virostko JM; Wyatt SK; Shah C; McKinley ET; Xie J; Mutic NJ; Washington MK; LaFleur B; Tantawy MN; Peterson TE; Ansari MS; Baldwin RM; Rothenberg ML; Bornhop DJ; Gore JC; Coffey RJ
    Clin Cancer Res; 2008 Nov; 14(22):7413-22. PubMed ID: 19010858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer.
    Schatz CA; Zitzmann-Kolbe S; Moen I; Klotz M; Nair S; Stargard S; Bjerke RM; Wickstrøm Biseth K; Feng YZ; Indrevoll B; Cruciani V; Karlsson J; Haendler B; Nielsen CH; Alfsen MZ; Hammer S; Hennekes H; Cuthbertson A; Hagemann UB; Larsen Å
    Clin Cancer Res; 2024 Jun; 30(11):2531-2544. PubMed ID: 38593212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin.
    Reissig F; Zarschler K; Novy Z; Petrik M; Bendova K; Kurfurstova D; Bouchal J; Ludik MC; Brandt F; Kopka K; Khoylou M; Pietzsch HJ; Hajduch M; Mamat C
    Theranostics; 2022; 12(17):7203-7215. PubMed ID: 36438496
    [No Abstract]   [Full Text] [Related]  

  • 14. Preclinical Evaluation of
    Banerjee SR; Lisok A; Minn I; Josefsson A; Kumar V; Brummet M; Boinapally S; Brayton C; Mease RC; Sgouros G; Hobbs RF; Pomper MG
    J Nucl Med; 2021 Jul; 62(7):980-988. PubMed ID: 33246975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody.
    Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X
    Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.